Patrick D. Yeramian - Chief Medical Officer at Amylyx Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
AMLX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patrick D. Yeramian since 06 Mar 2025

Holdings reported by Patrick D. Yeramian for Amylyx Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 205,605 $3,357,139 $16.33 09 Jan 2024 Direct
Stock Option (right to buy) 33,770 15 May 2023 Direct Common Stock

Transactions reported by Patrick D. Yeramian for Amylyx Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.